BACKGROUND: Enlarged ventricles and reduced hippocampal volume are consistently found in patients with first-episode schizophrenia. Studies investigating brain structure in antipsychotic-naive patients have generally focused on the striatum. In this study, we examined whether ventricular enlargement and hippocampal and caudate volume reductions are morphological traits of antipsychotic-naive first-episode schizophrenia. METHODS: We obtained high-resolution 3-dimensional T1-weighted magnetic resonance imaging scans for 38 antipsychotic-naive first-episode schizophrenia patients and 43 matched healthy controls by use of a 3-T scanner. We warped the brain images to each other by use of a high-dimensional intersubject registration algorithm. We performed voxel-wise group comparisons with permutation tests. We performed small volume correction for the hippocampus, caudate and ventricles by use of a false discovery rate correction (p < 0.05) to control for multiple comparisons. We derived and analyzed estimates of brain structure volumes. We grouped patients as those with (n = 9) or without (n = 29) any lifetime substance abuse to examine the possible effects of substance abuse. RESULTS: We found that hippocampal and caudate volumes were decreased in patients with first-episode schizophrenia. We found no ventricular enlargement, differences in global volume or significant associations between tissue volume and duration of untreated illness or psychopathology. The hippocampal volume reductions appeared to be influenced by a history of substance abuse. Exploratory analyses indicated reduced volume of the nucleus accumbens in patients with first-episode schizophrenia. LIMITATIONS: This study was not a priori designed to test for differences between schizophrenia patients with or without lifetime substance abuse, and this subgroup was small. CONCLUSION: Reductions in hippocampal and caudate volume may constitute morphological traits in antipsychotic-naive first-episode schizophrenia patients. However, the clinical implications of these findings are unclear. Moreover, past substance abuse may accentuate hippocampal volume reduction. Magnetic resonance imaging studies addressing the potential effects of substance abuse in antipsychotic-naive first-episode schizophrenia patients are warranted.
BACKGROUND: Enlarged ventricles and reduced hippocampal volume are consistently found in patients with first-episode schizophrenia. Studies investigating brain structure in antipsychotic-naive patients have generally focused on the striatum. In this study, we examined whether ventricular enlargement and hippocampal and caudate volume reductions are morphological traits of antipsychotic-naive first-episode schizophrenia. METHODS: We obtained high-resolution 3-dimensional T1-weighted magnetic resonance imaging scans for 38 antipsychotic-naive first-episode schizophreniapatients and 43 matched healthy controls by use of a 3-T scanner. We warped the brain images to each other by use of a high-dimensional intersubject registration algorithm. We performed voxel-wise group comparisons with permutation tests. We performed small volume correction for the hippocampus, caudate and ventricles by use of a false discovery rate correction (p < 0.05) to control for multiple comparisons. We derived and analyzed estimates of brain structure volumes. We grouped patients as those with (n = 9) or without (n = 29) any lifetime substance abuse to examine the possible effects of substance abuse. RESULTS: We found that hippocampal and caudate volumes were decreased in patients with first-episode schizophrenia. We found no ventricular enlargement, differences in global volume or significant associations between tissue volume and duration of untreated illness or psychopathology. The hippocampal volume reductions appeared to be influenced by a history of substance abuse. Exploratory analyses indicated reduced volume of the nucleus accumbens in patients with first-episode schizophrenia. LIMITATIONS: This study was not a priori designed to test for differences between schizophreniapatients with or without lifetime substance abuse, and this subgroup was small. CONCLUSION: Reductions in hippocampal and caudate volume may constitute morphological traits in antipsychotic-naive first-episode schizophreniapatients. However, the clinical implications of these findings are unclear. Moreover, past substance abuse may accentuate hippocampal volume reduction. Magnetic resonance imaging studies addressing the potential effects of substance abuse in antipsychotic-naive first-episode schizophreniapatients are warranted.
Authors: Jorge Jovicich; Silvester Czanner; Douglas Greve; Elizabeth Haley; Andre van der Kouwe; Randy Gollub; David Kennedy; Franz Schmitt; Gregory Brown; James Macfall; Bruce Fischl; Anders Dale Journal: Neuroimage Date: 2005-11-21 Impact factor: 6.556
Authors: Benedicto Crespo-Facorro; Roberto Roiz-Santiáñez; José María Pelayo-Terán; Cesar González-Blanch; Rocío Pérez-Iglesias; Agustín Gutiérrez; Enrique Marco de Lucas; Diana Tordesillas; José Luis Vázquez-Barquero Journal: Schizophr Res Date: 2007-02-15 Impact factor: 4.939
Authors: Siew E Chua; Charlton Cheung; Vinci Cheung; Jack T K Tsang; Eric Y H Chen; Jason C H Wong; Jason P Y Cheung; Lawrance Yip; Kin-Shing Tai; John Suckling; Gráinne M McAlonan Journal: Schizophr Res Date: 2006-11-13 Impact factor: 4.939
Authors: Andreas Glenthoj; Birte Y Glenthoj; Torben Mackeprang; Anne K Pagsberg; Ralf P Hemmingsen; Terry L Jernigan; William F C Baaré Journal: Psychiatry Res Date: 2007-03-13 Impact factor: 3.222
Authors: Dennis Velakoulis; Stephen J Wood; Michael T H Wong; Patrick D McGorry; Alison Yung; Lisa Phillips; De Smith; Warrick Brewer; Tina Proffitt; Patricia Desmond; Christos Pantelis Journal: Arch Gen Psychiatry Date: 2006-02
Authors: Eric Plitman; Raihaan Patel; Jun Ku Chung; Jon Pipitone; Sofia Chavez; Francisco Reyes-Madrigal; Gladys Gómez-Cruz; Pablo León-Ortiz; M Mallar Chakravarty; Camilo de la Fuente-Sandoval; Ariel Graff-Guerrero Journal: Neuropsychopharmacology Date: 2016-06-08 Impact factor: 7.853
Authors: Margaret Quinn; Maureen McHugo; Kristan Armstrong; Neil Woodward; Jennifer Blackford; Stephan Heckers Journal: Psychiatry Res Neuroimaging Date: 2018-08-03 Impact factor: 2.376
Authors: Nathan L Hutcheson; David G Clark; Mark S Bolding; David M White; Adrienne C Lahti Journal: Psychiatry Res Date: 2013-10-22 Impact factor: 3.222